Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
WINT similar filings
- 1 Oct 20 Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
- 29 Sep 20 Other Events
- 17 Sep 20 Entry into a Material Definitive Agreement
- 20 Aug 20 Regulation FD Disclosure
- 14 Aug 20 Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
- 23 Jul 20 Departure of Directors or Certain Officers
- 15 Jul 20 Departure of Directors or Certain Officers
Filing view
External links
Exhibit 99.1
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide01.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide02.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide03.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide04.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide05.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide06.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide07.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide08.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide09.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide10.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide11.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide12.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide13.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide14.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide15.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide16.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide17.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide18.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide19.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide20.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide21.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide22.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide23.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide24.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide25.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide26.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide27.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide28.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide29.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide30.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide31.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide32.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide33.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide34.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide35.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide36.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide37.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide38.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide39.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide40.jpg)
![](https://capedge.com/proxy/8-K/0001437749-20-018484/slide41.jpg)